|01/21/15||CareFusion Stockholders Approve Proposed Merger With Becton, Dickinson|
|FRANKLIN LAKES, N.J. and SAN DIEGO, Jan. 21, 2015 /PRNewswire/ -- Becton, Dickinson and Company (NYSE: BDX) ("BD") and CareFusion Corporation (NYSE: CFN) ("CareFusion") today announced the results of the CareFusion special meeting of stockholders, held on January 21, 2015, for CareFusion stockholders to consider and vote upon the proposed merger of CareFusion and BD. CareFusion stockholders approved the definitive merger agreement and the merger transaction, with approximately 76% of shares out... |
|11/20/14||Becton Dickinson And CareFusion Announce Expiration Of HSR Act Waiting Period In Proposed Transaction|
|FRANKLIN LAKES, N.J. and SAN DIEGO, Nov. 20, 2014 /PRNewswire/ -- Becton, Dickinson and Company (NYSE: BDX) ("BD") and CareFusion Corporation (NYSE: CFN) ("CareFusion") today announced that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the "HSR Act"), in connection with BD's proposed acquisition of CareFusion expired on November 19, 2014.
As previously announced on October 5, 2014, BD and CareFusion entered into a definitive agreement pursua... |
|11/06/14||CareFusion Reports First Quarter Fiscal 2015 Results|
|- Revenue increased 11 percent to $922 million
- Diluted earnings per share (EPS) from continuing operations totaled $0.37 on a GAAP basis and increased 14 percent from the prior year period to $0.50 per adjusted share
- Company increases fiscal 2015 adjusted diluted EPS guidance range to $2.80 to $2.95, driven primarily by a second quarter tax settlement with the Internal Revenue Service
SAN DIEGO, Nov. 6, 2014 /PRNewswire/ -- CareFusion Corp. (NYSE: CFN), a leading, global medical tec... |
|10/05/14||BD to Acquire CareFusion for $12.2 Billion|
|Combination of Complementary Portfolios Creates Global Leader in Medication Management and Patient Safety Solutions.
Franklin Lakes, NJ and San Diego, CA (October 5, 2014) – BD (NYSE: BDX) and CareFusion (NYSE: CFN) announced today a definitive agreement under which BD will acquire CareFusion for $58.00 per share in cash and stock, or a total of $12.2 billion, to create a global leader in medication management and patient safety solutions. The agreement has been unanimously approve... |